Review of the 2024 San Antonio Breast Cancer Symposium

February 7, 2025

This program is designed to discuss the content presented at the 2024 San Antonio Breast Cancer Symposium. Topics surrounding experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease will be highlighted.

Target Audience

Physicians, researchers, advanced practice providers, nurses, and other health care professionals who work with individuals with breast cancer.

Learning Objectives

 • Apply cutting edge research in medical and surgical breast oncology into clinical practice

• Discuss advancements made in radiation oncology related to breast cancer

• Identify the current initiatives surrounding palliative and supportive care within breast cancer management

• Recall premalignant disease management with breast oncology

• Recognize efforts involved in breast cancer health maintenance, prevention, and survivorship

• Understand the mechanism of action for the most current pharmaceutical advancements

Additional Information

AttachmentSize
PDF icon Final Brochure 272025.pdf170.44 KB
Course summary
Available credit: 
  • 4.25 AAPA Category I CME
  • 4.25 ACPE Pharmacy
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
  • 4.25 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 4.25 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 4.25 ASWB
  • 4.25 Attendance
Course opens: 
11/15/2024
Course expires: 
06/01/2025
Event starts: 
02/07/2025 - 7:00am EST
Event ends: 
02/07/2025 - 5:00pm EST
Cost:
$1.00
The Assembly
5051 Centre Avenue
Pittsburgh, PA
United States

Faculty
Parul Barry, MD, FACRO
Clinical Assistant Professor,
Department of Radiation Oncology
University of Pittsburgh School of Medicine
Radiation Oncologist
UPMC Hillman Cancer Center

Michael Cowher, MD
Associate Professor of Surgery,
University of Pittsburgh School of Medicine
Director, Breast Program
UPMC Jameson

Adam Brufsky, MD, PhD, FACP
Professor of Medicine and Associate Chief, Division of Hematology Oncology, 
University of Pittsburgh School of Medicine
Medical Director, Magee-Womens Cancer Program
Associate Director, Clinical Investigations, UPMC Hillman Cancer Center
Co-Director, Comprehensive Breast Cancer Center, UPMC Magee-Womens Hospital

Emilia Diego, MD
Vice-Chair, Diversity and Inclusion; Associate Professor of Surgery,
University of Pittsburgh School of Medicine
Program Director, Breast Surgical Oncology Fellowship; Director, Pre-Menopausal 
Breast Cancer Program,
UPMC Magee-Womens Hospital
Division Chief, Breast Surgery; Co-Director,
UPMC Hillman Cancer Center and Magee-Womens Hospital Breast Cancer Program

Julia Foldi, MD, PhD
Assistant Professor of Medicine,
Division of Malignant Hematology and 
Medical Oncology
University of Pittsburgh School of Medicine
Medical Oncologist
UPMC Hillman Cancer Center

Charles Geyer, MD, FACP
Interim Chief, Professor of Medicine
Division of Malignant Hematology 
and Medical Oncology,
University of Pittsburgh School of Medicine
Breast Medical Oncologist
UPMC Hillman Cancer Center

Rahul Kumar, MD
Clinical Assistant Professor,
Department of Radiation Oncology
University of Pittsburgh School of Medicine
Radiation Oncologist
UPMC Hillman Cancer Center

Kit Lu, MD
Director, Clinical Trials Program 
Associate Director,
UPMC Hillman Cancer Center, Central PA 
Clinical Assistant Professor,
University of Pittsburgh School of Medicine

Kristin Lupinacci, DO, FACOS, FACS
Assistant Professor of Surgery,
University of Pittsburgh School of Medicine
Breast Surgical Oncologist
UPMC Magee-Womens Hospital

Phuong Mai, MD, MS
Associate Professor,
Obstetrics, Gynecology, and Reproductive Sciences
UPMC Magee Center for Medical Genetics and Genomics
UPMC Hillman Cancer Center

Meaghan Marley, MD
Breast Surgical Oncologist
UPMC Altoona
UPMC Magee-Womens Hospital

Priya Rastogi, MD
Professor, University of Pittsburgh School of Medicine
Medical Oncologist
Magee-Womens Hospital

Priscilla McAuliffe, MD, PhD, FACS
Breast Surgical Oncologist,
UPMC Hillman Cancer Center
Assistant Professor of Surgery,
Division of Surgical Oncology
University of Pittsburgh School of Medicine

Steffi Oesterreich, PhD
Professor, University of Pittsburgh
School of Medicine
Co-Director, Women’s Cancer Research Center
Magee-Womens Research Institute
Co-Leader, Cancer Biology Prog

Faculty Disclosure

All individuals in a position to control the content of this education activity have disclosed all financial relationships with any 
companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on 
patients.

All the relevant financial relationships for the individuals listed below have been mitigated:
Parul Barry: ACRO, Beckwith Institute, Pittsburgh Foundation, SilverIon (Grant/Research Support); Elsevier Pathways 
(Consultant); Osler Board Review, ASTRO, ACRO, Onclive, Varian (Honorarium); ASTRO and ACRO (Travel expenses)
Adam Brufsky: Agendia, AstraZeneca (Grant/Research Support); AstraZeneca, Pfizer, Novartis, Lilly, Genentech/Roche, 
SeaGen, Daiichi Sankyo, Merck, Agendia, Sanofi, Puma (Consultant)
Charles Geyer: AstraZeneca, Daiichi Sankyo, Exact Sciences, and Genentech/Roche (Grant/Research Support)
Kit Lu: AstraZeneca, Daiichi Sankyo, Gilead, Merck, Stemline, and Seagen (CE Speaker’s Bureau)
Priscilla McAuliffe: AstraZeneca (Consultant)
Dhaval Mehta: AstraZeneca, Curio Science, and Integra Connect (Consultant)
Shannon Puhalla: AstraZeneca and Novartis (Consultant)

No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position
to control the content of this education activity have relevant financial relationships with any companies whose primary business 
is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 4.25 contact hours.

Physician Assistant (AAPA)
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.  

Pharmacy (CPE)
This knowledge-based activity provides 4.25 contact hours of continuing pharmacy education credit.  

Social Work (ASWB)
As a Jointly Accredited Organization, the University of Pittsburgh is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 4.25 continuing education credits.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity. 

Available Credit

  • 4.25 AAPA Category I CME
  • 4.25 ACPE Pharmacy
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
  • 4.25 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 4.25 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 4.25 ASWB
  • 4.25 Attendance

We gratefully acknowledge support from the following exhibitors for this activity:

AbbVie, American Cancer Society, Amgen, AstraZeneca, Bayer Pharmaceuticals, Inc., BeiGene, Cancer Bridges, Daiichi Sankyo, Inc., Gilead Oncology, Guardant Health, Hologic, Lilly Oncology, Menarini Stemline Therapeutics, Merck, NeoGenomics, Novartis Oncology, Pfizer, Pittsburgh Hearts of Steel, UPMC Moving Through Cancer Program, and Young Adult Survivors United

Price

Cost:
$1.00
Please login or register to take this course.